Advertisement

Medical Oncology

, Volume 24, Issue 4, pp 469–471 | Cite as

Two cases of sarcoidosis-lymphoma syndrome

  • Nada Suvajdzic
  • Branislava Milenkovic
  • Maja Perunicic
  • Jelena Stojsic
  • Snezana Jankovic
Case

Abstract

An association between sarcoidosis and lymphoproliferative diseases (LD), the sarcoidosis-lymphoma syndrome, has been previously described, and may be attributed to the underlying immunological abnormalities that occur during the sarcoidosis disease process.

We report two patients who developed Hodgkin’s disease and diffuse large B-cell non-Hodgkin’s lymphoma (NHL) subsequent to their diagnosis of sarcoidosis after latency periods of 6 years and 18 years respectively. Both patients developed histologically-proven sarcoidosis late in life, at 46 years and 58 years, and had differing clinical courses. The first had radiographically staged II chronic progressive respiratory sarcoidosis (RS) and required long-term methotrexate to control the disease, while the second achieved a spontaneous remission of her stage I intrathoracic RS. After treatment, the patient with Hodgkin’s disease remains in remission 2.5 years following six cycles of ABVD protocol chemotherapy and involved-field radiotherapy, while the NHL patient remains in remission at 3 years following six cycles of R-COP protocol chemotherapy.

Clinicians should be aware of the potential risks of malignancy, and especially of LD in sarcoidosis patients. They should be alerted to the possibility of additional pathology by any atypical clinical features, and should biopsy new lesions and adenopathy to exclude any coexistent neoplasm.

Keywords

Sarcoidosis Lymphoma 

Notes

Acknowledgments

We would very much like to thank Dr Henry Dushan Edward Atkinson, Imperial College Medical School, St Mary’s Hospital, Praed Street, London W2 1NY, UK for his critical review and assistance in the writing of this article.

References

  1. 1.
    Brincker H, Wilbek E The incidence of malignant tumors in patients with respiratory sarcoidosis. Br J Cancer (1974);29:247–51.PubMedGoogle Scholar
  2. 2.
    Suen JS, Forse MS, Hyland RH, Chan CK The malignancy-sarcoidosis syndrome. Chest (1990);989:1300–2.Google Scholar
  3. 3.
    Karakantza M et al Association between sarcoidosis and lymphoma. J Clin Pathol (1996);49:208–12.PubMedCrossRefGoogle Scholar
  4. 4.
    Brincker H The sarcoidosis-lymphoma syndrome. Br J Cancer (1986);54:467–73.PubMedGoogle Scholar
  5. 5.
    Tufan A et al Concurrent presentations of the sarcoidosis, tuberculosis and lymphoma in a single patient. Resp Med (2006);100:951–53.CrossRefGoogle Scholar
  6. 6.
    Merchant TE, Filippa DA, Yahalom J Sarcoidosis following chemotherapy for Hodgkin’s disease. Leuk Lymphoma (1994);13:339–47.PubMedGoogle Scholar
  7. 7.
    Nakamura Y et al Muscle sarcoidosis following malignant lymphoma: diagnosis by MR imaging. Skeletal Radiol (2002);31:702–5.PubMedCrossRefGoogle Scholar
  8. 8.
    Kornacker M, Kraemer A, Leo E, Ho AD Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin’s lymphoma: report of two cases. Ann Hematol (2002);81:103–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Marschke RF Sarcoidosis and malignant neoplasm: the Mayo Clinic experience. Sarcoidosis (1986);3:149–150.Google Scholar
  10. 10.
    Askling J, Grunewald J, Eklund A, Hillerdal G, Ekbom A Increased risk for cancer following sarcoidosis. Am J Respir Crit Care Med (1999);160:1668–72.PubMedGoogle Scholar
  11. 11.
    Vourlekis JS, Sawyer RT, Newman LS Sarcoidosis: developments in etiology, immunology and therapeutics. Adv Inter Med (2000);45:209–57.Google Scholar
  12. 12.
    Römer FK, Hommelgaard P, Schou G Sarcoidosis and cancer revisited: a long term follow-up study of 555 Danish sarcoidosis patients. Eur Respir J (1998);12:906–12.PubMedCrossRefGoogle Scholar
  13. 13.
    Seersholm N, Vestbo J, Viskum K Risk of malignant neoplasms in patients with pulmonary sarcoidosis. Thorax (1997);52:892–4.PubMedCrossRefGoogle Scholar
  14. 14.
    Yamagouchi M et al Excess death of lung cancer among sarcoidosis patients. Sarcoidosis (1991);8:51–5.Google Scholar
  15. 15.
    Reich JM, Mullooly JP, Johnson RE Linkage analysis of malignancy-associated sarcoidosis. Chest (1995);107:605–13.PubMedGoogle Scholar
  16. 16.
    Brincker H Sarcoid reactions in malignant tumours. Cancer Treat Rev (1986);13:147–156.PubMedCrossRefGoogle Scholar
  17. 17.
    American Thoracic Society. Statement on sarcoidosis. Am J Crit Care Med (1999);160:736–55.Google Scholar

Copyright information

© Humana Press Inc. 2007

Authors and Affiliations

  • Nada Suvajdzic
    • 1
  • Branislava Milenkovic
    • 2
  • Maja Perunicic
    • 1
  • Jelena Stojsic
    • 2
  • Snezana Jankovic
    • 1
  1. 1.Institute of HematologyClinical Center of SerbiaBelgradeSerbia and Montenegro
  2. 2.Institute for Pulmonary Diseases and TBClinical Center of SerbiaBelgradeSerbia and Montenegro

Personalised recommendations